Latest Adverse effect Stories
The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).
A weight-loss drug currently under a second review from the Food and Drug Administration (FDA) is causing concerns that it may be responsible for birth defects and heart problems, according to documents released by the agency on Friday.
On Jan. 18th 2012, the Honorable Judge Carol E. Higbee ordered an extended deadline for the sixth wave of core discovery for the Accutane lawsuit mass tort in New Jersey.
On Jan. 28th and Feb.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.